ProShare Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-39,815
Closed -$492K 2284
2024
Q4
$492K Buy
39,815
+28,066
+239% +$321K ﹤0.01% 1281
2024
Q3
$134K Buy
+11,749
New +$118K ﹤0.01% 1833
2024
Q2
Sell
-11,272
Closed -$75.5K 2028
2024
Q1
$75.5K Buy
11,272
+999
+10% +$6.87K ﹤0.01% 1861
2023
Q4
$66.8K Buy
+10,273
New +$66.2K ﹤0.01% 1828
2022
Q2
Sell
-13,471
Closed -$275K 2178
2022
Q1
$275K Sell
13,471
-1,639
-11% -$33.4K ﹤0.01% 1687
2021
Q4
$442K Buy
+15,110
New +$432K ﹤0.01% 1548
2021
Q3
Sell
-15,666
Closed -$402K 2305
2021
Q2
$402K Sell
15,666
-481
-3% -$10.3K ﹤0.01% 1691
2021
Q1
$294K Buy
16,147
+3,661
+29% +$60.8K ﹤0.01% 1819
2020
Q4
$144K Buy
+12,486
New +$114K ﹤0.01% 1930
2016
Q2
Sell
-4,017
Closed -$12K 1620
2016
Q1
$12K Sell
4,017
-141
-3% -$755 ﹤0.01% 1581
2015
Q4
$34K Buy
4,158
+1,436
+53% +$11.6K ﹤0.01% 1689
2015
Q3
$19K Sell
2,722
-673
-20% -$5.62K ﹤0.01% 1434
2015
Q2
$31K Sell
3,395
-1,476
-30% -$14.2K ﹤0.01% 1634
2015
Q1
$46K Sell
4,871
-535
-10% -$5.15K ﹤0.01% 1873
2014
Q4
$53K Sell
5,406
-4,602
-46% -$46.3K ﹤0.01% 1914
2014
Q3
$95K Sell
10,008
-2,268
-18% -$25.4K ﹤0.01% 2175
2014
Q2
$162K Sell
12,276
-10,914
-47% -$138K ﹤0.01% 2248
2014
Q1
$308K Buy
23,190
+21,465
+1,244% +$283K ﹤0.01% 2220
2013
Q4
$17K Sell
1,725
-11,956
-87% -$113K ﹤0.01% 1327
2013
Q3
$135K Buy
+13,681
New +$136K ﹤0.01% 2333

Other funds holding CDMO

ProShare Advisors's CDMO Position: Q1 2025 in Review

ProShare Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 39,815 shares — an estimated $492K sold.

ProShare Advisors first reported a position in CDMO in Q3 2013 and held it in 20 quarters. The position peaked at $492K in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • ProShare Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • ProShare Advisors sold 39,815 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $492K.
  • ProShare Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2013 and held it in 20 quarters.
  • ProShare Advisors's Avid Bioservices, Inc. Common Stock position peaked at $492K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on ProShare Advisors's 13F filing for Q1 2025, filed 8 May 2025.